SCHEMBL20042839

SCHEMBL20042839

Cc1nc2c(c(N3CCC3)n1)CN(C(=O)c1ccccc1)C2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.45
CNR1 P21554 1/20 0.45
CNR2 P34972 1/20 0.45
GPR55 Q9Y2T6 1/20 0.45
GBA1 P04062 2/20 0.44
CFTR P13569 1/20 0.43
MTOR P42345 3/20 0.43
HPGD P15428 2/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 2/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SMO Q99835 2/20 0.41
MTHFD2 P13995 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20042817 0.90 PKM (0.44) P2RX7GBA1HPGDMEN1KMT2A
SCHEMBL20042668 0.89 HPGD (0.51) P2RX7GBA1HPGDMEN1KMT2A
SCHEMBL20042685 0.88 HTT (0.42) P2RX7GBA1L3MBTL1SMN1; SMN2HTT
SCHEMBL20042751 0.88 HSD17B10 (0.49) P2RX7GBA1HPGDMEN1KMT2A
SCHEMBL20042832 0.88 CFTR (0.45) P2RX7CFTRHPGDMEN1KMT2A
SCHEMBL20042771 0.87 P2RX7 (0.47) P2RX7HPGDMEN1KMT2AL3MBTL1
SCHEMBL20042684 0.87 SMN1; SMN2 (0.52) P2RX7HPGDALDH1A1TSHRSMN1; SMN2
SCHEMBL20042776 0.86 P2RX7 (0.41) P2RX7CNR1CNR2GPR55GBA1
SCHEMBL20042743 0.85 P2RX7 (0.40) P2RX7CNR1CNR2GPR55GBA1
SCHEMBL20042728 0.85 MEN1 (0.42) GBA1MEN1KMT2AL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed